402
Participants
Start Date
September 30, 2011
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Nicorandil
The subjects will receive Nicorandil 5 mg tablet orally three times daily for a period of 12 weeks along with the standard treatment.
Standard Treatment
The subjects will receive one of the standard anti-anginal therapies which included but not limited to aspirin, ACEI, lipid lowering statins and beta blockers according to the recommendation of guidelines. If the subject's condition permitted, they should take all these medicines. However, the dose, route, frequency and duration were determined by investigators according to subject's specific condition.
For Locations in, Beijing
Merck Serono Co., Ltd., China
INDUSTRY
Merck KGaA, Darmstadt, Germany
INDUSTRY